3RH Muller, R Becker, B Kruss, et al. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution[P]. United States Patent 5,858,410, Medac Geseitschaft far Klinische Spezialpraparate mbH, 1999.
4Claudia Jacobs, Rainer Helmut Muller. Production and characterization of a budesonide nanosuspension for pulmonary administration[J]. Pharm Res, 2002,19(2): 189-194.
5C Jacobs, O Kayser, RH Mfiller. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide[J]. Int J Pharm, 2000, 196(2) : 161-164.
6K Peters, S Leitzke, JE Diederichs, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection[J]. J Antimicrob Chemother, 2000, 45 (1) : 77-83.
7KP Krause, O Kayser, K Mader, et al. Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation[J]. Int J Pharrn,2000,196(2) : 169-172.
8JE Kipp, Wong, JCT, et al. Microprecipitation Method For Preparing Submieron Suspensions[P]. United States Patent 6,607,784, Baxter International Inc. (Deerfield, IL), USA, 2003.
9Henriksen, Mishra, Pace, et al. Insoluble drug delievery[P], International Patent 97/14407, Triangle Pharmaceuticals, The university of Texas system, April 24,1997.
10James E. Kipp, Mark J. Doty,CL. Rebbeck, etal. Compositions of and Method for Preparing Stable Partieiles in a Frozen Aqueous Matrix[P], United States Patent 7,112,340, Baxter International Inc. (Deerfield, IL) Sep. 26, 2006.